Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

A researcher at the University of North Carolina at Chapel Hill received a $1.48 million grant from the National Institutes of Health to support research into Recomparin, a synthetic version of the blood thinner heparin, according to the Triangle Business Journal. Associate Professor of Pharmacy Jian Liu invented the synthetic anticoagulant and hopes the grant money will help him perfect the drug and find better ways of synthesizing it.

Read the rest of this entry »

In an effort to ship heparin- and saline-filled syringes faster, workers at a facility in North Carolina failed to check sterility and then falsified manufacturing dates to make it appear those safeguards were followed, according to an Associated Press report. Those syringes, as it turned out, were tainted with a bacteria known as Serratia marcescens and may have lead to five deaths and hundreds of infections in those who received them.

Read the rest of this entry »

Meet Allie Beaty. As a diabetic, her life depends on insulin. She wants to make a difference for others like her, make “the world safer for people with diabetes,” she says on her Web page, Alliesvoice.com. So Allie established a diabetes think group and shares ”Love Diabetes” videos on YouTube to push her mission.

Read the rest of this entry »

Scientists at University of North Carolina at Chapel Hill have learned to modify the human enzyme that produces heparin, which may lead to a more effective synthetic version of the blood thinner, according to Newswise Medical News.

Read the rest of this entry »